Combination Therapy With Sodium Dichloroacetate and Potassium-Sodium Citrate in Patients With Stage IV Pancreatic Cancer

Sodium dichloroacetate (DCA), which reverses the Warburg effect of cancer cells, contributes to the alkalinization of the tumor along with a mixture of potassium-sodium (K/Na) citrate hydrate. We retrospectively evaluated the effect of the combination therapy of these in patients with stage IV pancreatic cancer. A total of 135 patients from February 2019 to August 2026 were included in this study. Eligible patients were divided into four groups: group D (DCA alone every other day), group DC (both DCA and K/Na citrate every other day), group D/C (either DCA or K/Na citrate on alternating days), and group DX (DCA every other day with ivermectin and tamoxifen every third DCA treatment). Simple pairwise comparisons of the Kaplan-Meier survival curves using the log-rank test showed significant differences between the D and DC groups and between the DC and DX groups, whereas no significant differences were observed in the other pairwise comparisons. On the other hand, the multivariable time-dependent Cox regression analysis, which accounts for the time from diagnosis to the initiation of treatment, showed a significantly higher hazard in the D, D/C, and DX groups than in the DC group. These findings suggest a potential survival benefit associated with the combination of DCA and K/Na citrate.

Authors

Publication Details

Journal
Cureus
Published
2026-11-16
DOI
https://doi.org/10.7759/cureus.119739
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Combination Therapy With Sodium Dichloroacetate and Potassium-Sodium Citrate in Patients With Stage IV Pancreatic Cancer

Hiromasa Kurosaki, Ryumei H Ishiguro, H. Terunuma, Miyu Ishiguro et al.
1 links
Cureus
Pancreatic and Hepatic Oncology Research
article

Combination Therapy With Sodium Dichloroacetate and Potassium-Sodium Citrate in Patients With Stage IV Pancreatic Cancer

Hiromasa Kurosaki, Ryumei H Ishiguro, H. Terunuma, Miyu Ishiguro, Atsushi Toki, Tatsuaki Ishiguro
article en

Abstract

Sodium dichloroacetate (DCA), which reverses the Warburg effect of cancer cells, contributes to the alkalinization of the tumor along with a mixture of potassium-sodium (K/Na) citrate hydrate. We retrospectively evaluated the effect of the combination therapy of these in patients with stage IV pancreatic cancer. A total of 135 patients from February 2019 to August 2026 were included in this study. Eligible patients were divided into four groups: group D (DCA alone every other day), group DC (both DCA and K/Na citrate every other day), group D/C (either DCA or K/Na citrate on alternating days), and group DX (DCA every other day with ivermectin and tamoxifen every third DCA treatment). Simple pairwise comparisons of the Kaplan-Meier survival curves using the log-rank test showed significant differences between the D and DC groups and between the DC and DX groups, whereas no significant differences were observed in the other pairwise comparisons. On the other hand, the multivariable time-dependent Cox regression analysis, which accounts for the time from diagnosis to the initiation of treatment, showed a significantly higher hazard in the D, D/C, and DX groups than in the DC group. These findings suggest a potential survival benefit associated with the combination of DCA and K/Na citrate.

Cureus
Good health and well-being
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon